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Strengths and limitations of this study
 ► This is the largest analysis of patients with facial 
wounds treated in coalition medical treatment facil-
ity (MTF) in Iraq and Afghanistan.
 ► It is the first study to directly compare treatment 
delivered by US and UK military medical providers.
 ► It additionally reports data from local nationals en-
abling trends to be identified in which facial frac-
tures in particular were treated.
 ► The lack of standardisation between the two trauma 
registries limits further outcome analyses between 
nations.
 ► It is not possible to collate long- term outcome data 
in the US system due to the lack of uniformity of 
reporting methods.
AbStrACt
Objectives To perform the first direct comparison of the 
facial injuries sustained and treatment performed at USA 
and UK deployed medical treatment facilities (MTFs) in 
support of the military campaigns in Iraq and Afghanistan.
Setting The US and UK Joint Theatre Trauma Registries 
were scrutinised for all patients with facial injuries 
presenting alive to a UK or US deployed MTF between 1 
March 2003 and 31 October 2011.
Participants US and UK military personnel, local police, 
local military and civilians.
Primary and secondary outcome measures An 
adjusted multiple logistic regression model was performed 
using tracheostomy as the primary dependent outcome 
variable and treatment in a US MTF, US or UK military, 
mandible fracture and treatment of mandible fracture as 
independent secondary variables.
results Facial injuries were identified in 16 944 
casualties, with the most common being those to skin/
muscle (64%), bone fractures (36%), inner/middle ear 
(28%) and intraoral damage (11%). Facial injuries were 
equally likely to undergo surgery in US MTF as UK MTF 
(OR: 1.06, 95% CI 0.4603 to 1.142, p=0.6656); however, 
variations were seen in injury type treated. In US MTF, 
692/1452 (48%) of mandible fractures were treated by 
either open or closed reduction compared with 0/167 (0%) 
in UK MTF (χ2: 113.6; p≤0.0001). US military casualties 
who had treatment of their mandible fracture (open 
reduction and internal fixation or mandibulo- maxillary 
fixation) were less likely to have had a tracheostomy than 
those who did not undergo stabilisation of the fractured 
mandible (OR: 0.61, 95% CI 0.44 to 0.86; p=0.0066).
Conclusions The capability to surgically treat mandible 
fractures by open or closed reduction should be 
considered as an integral component of deployed coalition 
surgical care in the future.
IntrOduCtIOn
In support of military operations in the Iraq 
and Afghanistan, the USA and UK deployed 
numerous military medical treatment facili-
ties (MTFs). Their primary role was to treat 
coalition military forces, but as the mission 
evolved, treatment was offered to host 
nation police and military members, as well 
as the civilian population according to the 
prevailing ‘Rules of Eligibility’.1 Coalition 
MTF deployed to Iraq and Afghanistan are 
broadly classified by the North Atlantic Treaty 
Organization into roles (or echelons). Role 1 
provides primary healthcare with specialised 
first aid, triage, resuscitation and stabilisa-
tion.1 2 Role 2 MTF provide enhanced resus-
citation with capability for life- saving surgery, 
in addition to further triage and treatment 
of casualties. Role 2 facilities are divided into 
‘Basic (R2B)’, where damage control surgery 
(DCS) procedures can be undertaken, and 
‘Enhanced’ (R2E) with additional capabil-
ities and greater resources, including the 
capability to prepare casualties for strategic 
aeromedical evacuation (STRATEVAC).1 
Role 3 MTF provide all the capabilities of the 
R2E MTF as well as the capability for special-
ised imaging and surgery, blood banking and 
laboratory support.
The US military deployed surgeons 
formally trained in the management of 
facial skeletal trauma to their role 3 MTF at 
Balad (Iraq), Baghdad (Iraq) and Bagram 
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(Afghanistan).3 4 Further management of facial trauma in 
US military personnel occurred following STRATEVAC 
to Landstuhl Regional Medical Centre in Germany (role 
4), with a proportion further evacuated to homeland US 
facilities (role 5).4 5 The UK deployed surgeons formally 
trained in the management of facial trauma to the R3 
MTF in Camp Bastion and, for a shorter period, to the 
Canadian- led R3 MTF in Kandahar.6–9 Taught British prac-
tice was to repatriate patients with facial injury without 
stabilisation or fixation of the facial skeleton to the Royal 
Centre for Defence Medicine (RCDM) in Birmingham 
UK (role 4).6 7 10–13
Although both US and UK authors have previously 
published analyses of facial injuries sustained in Iraq and 
Afghanistan, comparing the results is challenging due to 
methodological differences. Accurate comparisons are 
relevant, as the US has a different approach to the UK 
in terms of surgical training and the range of deployed 
surgical specialties. This may have led to differences in 
the manner in which patients with facial injuries were 
treated. Those studies describing treatment undertaken in 
deployed MTF were generally based on a limited duration 
and/or used surgical logbooks that inevitably produce 
epidemiological and reporting bias.4 6–8 14 Existing papers 
can neither enable comparison of treatment performed 
at different deployed facilities, nor between popula-
tion subtypes such as host nation civilians or military 
personnel.15 16 For example, between 2005 and 2010, the 
Canadian- led role 3 MTF at Kandahar as part of Oper-
ation ATHENA treated 184 facial fractures but did not 
subdivide into fracture location or patient nationality.9 
Finally, the terminology used to describe the facial region 
has not been standardised between papers and includes 
‘head and neck’, ‘craniomaxillofacial’, ‘craniofacial’ and 
‘maxillofacial’.17 18 Analyses may include scalp and neck 
wounds, and these papers more often reflect the specialty 
of surgeon treating the wounds and not the anatom-
ical area.4 18 Potential comparisons between treatment 
performed at US and UK MTF is enabled by both nations 
using databases, which record injuries using Abbreviated 
Injury Scale (AIS) scores.16 17 19 To our knowledge, no 
authors have previously scrutinised the deployed trauma 
registries of both nations to enable direct comparisons of 
injuries and treatment. The aim of this analysis was there-
fore to compare incidence, injury types and treatment 
performed in Iraq and Afghanistan during the conflicts 
on US and UK military and host nation civilians during 
an extended period in order to inform future surgical 
skill sets and training requirements.
MethOdS
All facial injuries (AIS region 2) sustained by patients 
between 1 March 2003 and 31 October 2011 were 
extracted from the US Department of Defense Trauma 
Registry (DoDTR) and UK Joint Theatre Trauma Registry 
databases. Both databases are held as spreadsheets 
on a secure military server in each country with highly 
restricted access. Institutional approval was granted 
from the UK Royal Centre for Defence Medicine and 
US Joint Trauma Registry for both interrogation of data 
and publication of results. These dates were chosen for 
analysis as during that period both the US and UK were 
undertaking similar combat roles and activities. The US 
had greater numbers of persons treated at their MTFs as 
they had much higher numbers of troops on the ground, 
reflecting the relative sizes of their military commitments. 
Died of wounds (DoW) was defined as casualties who 
died after reaching an MTF. During this period, both 
US and UK military units were engaged in similar types 
of counterinsurgency warfare and were wearing compa-
rable types of personal armour. The Iraq conflict was 
described in the databases as Operation Iraqi Freedom 
(USA), Operation New Dawn (USA) or Operation TELIC 
(UK). The Afghanistan conflict was described as Opera-
tion Enduring Freedom (USA) or Operation HERRICK 
(UK). Population groups studied were USA, UK and 
other coalition military, host nation military and civilians. 
Host nation military primarily comprised Iraqi or Afghan 
National Army units. Host nation civilians included local 
police, such as the Afghan National Police.
Injuries in both registries were matched using AIS 
codes.20 Within the AIS system, the face is body region 2 
and comprises the skin and soft tissues, the maxillofacial 
bony skeleton, eyes and ears. Frontal bone, frontal sinus, 
head (scalp, cranial bones and intracranial) and neck 
wounds were excluded from this analysis. The primary 
outcome measure was requirement for surgical tracheos-
tomy as with the exception of mortality, no other measures 
exist for facial injuries in either database. AIS scoring 
of injuries in the facial region ranges from 1 to 4 and, 
within this system, death cannot be directly attributed to 
a facial injury (a score of 6 in the face and neck regions). 
Treatment performed in deployed US MTF was coded 
using the International Classification of Disease version 
9 codes. Treatment performed in deployed UK MTF was 
coded using the Classification of Interventions and Proce-
dures (OPCS) version 4.
Injury Severity Scores (ISS) were ISS split into terciles 
(tercile one=3–15; tercile two=16–24; tercile three=25–
75). An adjusted multiple logistic regression model was 
performed using tracheostomy as the dependent vari-
able and coalition casualty, ISS, mandible fracture and 
treatment of mandible fracture as independent variables. 
Reverse stepwise logistic regression was performed with 
a p value threshold of <0.05 for inclusion in the model. 
ORs were determined using a χ2 test with Yates’ conti-
nuity correction and reported with p values and CI. Data 
analysis was performed using Stata for Mac V.15.1.
reSultS
Patient demographics and injury mechanisms
Facial injuries were identified in 16 944/67 586 (25%) 
casualties who survived to reach a deployed MTF across 
both databases (table 1). A total of 8792 of 16 944 (52%) 
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Table 2 Cause of battle and disease and non- battle injury (DNBI) in patients with a facial wound
Mechanism
US military 
treated UK military
Other coalition 
military
Host nation 
military
Host nation 
civilians All
All battle (n (%)) 5303 (79) 512 (90) 655 (9) 2803 (83) 3990 (6) 13 263 (78)
  Explosive device 4637 (69) 470 (83) 583 (8) 2182 (65) 2837 (5) 10 709 (63)
  Gunshot Wound 349 (5) 39 (7) 40 (5) 465 (14) 792 (14) 1685 (10)
  Motor vehicle collision 116 (2) 0 (0) 2 (<1) 71 (2) 178 (3) 367 (2)
  Fall 29 (<1) 3 (<1) 2 (<1) 6 (<1) 16 (<1) 56 (<1)
  Helicopter crash 38 (<1) 0 (0) 8 (<1) 7 (<1) 9 (<1) 62 (<1)
  Other/not specified/
unknown
134 (2) 0 (0) 20 (3) 72 (2) 158 (3) 384 (2)
All non- battle (n (%)) 1380 (20) 53 (10) 108 (14) 573 (17) 1567 (28) 3681 (22)
  Motor vehicle collision 478 (7) 34 (6) 44 (5) 375 (11) 860 (15) 1791 (11)
  Fall 240 (4) 5 (1) 7 (1) 38 (1) 173 (3) 463 (3)
  Sharp object 26 (<1) 0 (0) 3 (<1) 3 (<1) 28 (<1) 60 (<1)
  Blunt object 142 (2) 0 (0) 9 (1) 3 (<1) 46 (<1) 200 (1)
  Helicopter crash 39 (<1) 10 (2) 5 (<1) 1 (<1) 3 (<1) 58 (<1)
  Machinery/equipment 73 (1) 0 (0) 7 (<1) 5 (<1) 50 (<1) 135 (<1)
  Other/not specified/
unknown
382 (5) 4 (<1) 33 (4) 148 (4) 407 (7) 974 (6)
All 6683 (100) 565 (100) 763 (100) 3376 (100) 5557 (100) 16 944 (100)
Incidences <10 are not shown to ensure anonymity.
were recorded as due to penetrating trauma, and 7702/16 
935 (45%) from blunt trauma. The most common mech-
anisms of injury were explosive events (10700/16 944, 
63%), motor vehicle collisions (2158/16 944, 13%) and 
gunshot wounds (1685/16 944, 10%, table 2).
types of facial injuries sustained in casualties that survived 
following treatment at role 2 and 3 MtFs
A total of 693 of 16 944 (4%) patients with facial injuries 
who arrived alive at MTF DoW and 16 251/16 944 (96%) 
survived. The most common facial injuries in survivors 
were to skin or muscle (10 319/16 251, 64%), facial bone 
fractures (5927/16 251, 37%), inner/middle ear damage 
(4486/16 251, 28%) and trauma to intraoral structures 
including teeth (1782/16 251, 11%, table 3).
treatment performed on survivors based on population 
cohorts
Across both databases, 4653/16 251 (29%) of survivors had 
procedures undertaken for facial injuries in the deployed 
setting (table 4). The most common was debridement of 
soft tissues of skin and muscle (3879/4653, 83%), treat-
ment of facial fractures (2217/4653, 48%) and surgical 
tracheostomy with facial injuries (1228/4653 (26%). 
Treatment of facial fractures was divided into those 
managed by open reduction and internal fixation (ORIF) 
or those stabilised by mandibulo- maxillary fixation 
(MMF). A single casualty may have had both ORIF and 
MMF for different fractures or to a single type of fracture, 
hence why the totals for ORIF and MMF combined 
exceed the figure for either surgery alone.
treatment performed on survivors based on MtF
Overall, patients with facial injuries were equally likely 
to undergo surgery in a US MTF and a UK MTF (OR: 
1.06, 95% CI 0.46 to 1.14, p=0.6656). However, some 
variation was identified in injury type treated (figure 1). 
Repair of skin/muscle injuries was proportionately more 
commonly recorded in a UK MTF compared with a US 
MTF (OR: 1.465, 95% CI 1.29 to 1.66, p≤0.0001). Repair 
of intraoral injuries was more commonly recorded in a 
US MTF compared with a UK MTF (OR: 1.706, 95% CI 
1.229 to 2.375, p≤0.0020). Vascular injuries were also 
more commonly recorded as having been treated in 
US MTF than UK MTF (231/367, 62.9% vs 19/42, 
45.2%; p=0.0301). However, there were more treatments 
recorded for facial vascular injuries in the US DoDTR 
than there were actual injuries recorded using AIS scores, 
demonstrating a discrepancy in recording. A total of 
1363 of 4189 (32.5%) of casualties (all patient cohorts) 
with facial fractures managed in US MTF were treated by 
ORIF or stabilised by MMF. ORIF or formal MMF was not 
performed in any of the 852 facial fractures seen in UK 
MTF. When analysing mandible fractures alone, in US 
MTF, 692/1452 (48%) of mandible fractures were stabi-
lised compared with 7/167 (1%) in UK MTF (χ2: 113.6; 
p≤0.0001). A total of 258 of 692 (37%) of the patients 
with stabilised mandible fractures in US MTF were 
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Table 3 Injuries to the facial region sustained in in the 16 251 survivors
Group
AIS 2005 
diagnosis codes
US military 
(n (%))
UK military 
(n (%))
Other coalition 
military (n (%))
Host nation 
military 
(n (%))
Host nation 
civilians 
(n (%)) Total (n (%))
All face wounds 200099–251902 6558 (100) 544 (100) 751 (100) 3206 (100) 5192 (100) 16 251 (100)
All facial fractures 250200–251404, 
251800–251902
2202 (35) 146 (27) 267 (4) 1318 (41) 1986 (38) 5919 (36)
Mandible fracture 250600–250699 694 (11) 50 (<1) 79 (11) 524 (16) 682 (13) 2029 (12)
Maxilla fracture 250 800–250810 1068 (16) 46 (<1) 105 (14) 561 (17) 893 (18) 2673 (16)
Zygoma fracture 251800–251814 682 (10) 21 (<1) 66 (9) 362 (11) 590 (11) 1721 (11)
Orbital wall 
fracture
251200–251236 796 (12) 55 (1) 77 (10) 475 (15) 769 (15) 2172 (13)
Nasal bone or 
septum fracture
251000, 251002, 
251006
667 (10) 34 (<1) 71 (<1) 319 (10) 437 (8) 1528 (9)
Intraoral injury 243000–250200, 
251402–251499
851 (13) 54 (1) 89 (12) 293 (9) 495 (10) 1782 (11)
Facial skin or 
muscle damage
210099–216008 4692 (72) 343 (63) 390 (52) 1844 (58) 3050 (6) 10 319 (63)
Facial vascular 
injury
220099, 220200–
220204
46 (<1) 2 (<1) 1 (<1) 26 (<1) 33 (<1) 108 (<1)
Inner or middle 
ear injury
240205–240208 1487 (23) 13 (<1) 124 (17) 374 (12) 2488 (48) 4486 (28)
Those 693 who DoW are excluded.
AIS, Abbreviated Injury Scale; DoW, died of wounds.
treated by ORIF, while the remainder was stabilised by 
MMF (table 5). The seven mandible fractures temporarily 
stabilised in UK MTF were treated with a bridle wire (a 
wire spanning the teeth around a fracture). No definitive 
fixation was undertaken in a UK MTF.
relationship between facial fracture treatment and 
aeromedical evacuation
It was not possible to accurately ascertain from the 
DoDTR the proportion of US military casualties with 
facial fractures who were evacuated; however, all UK mili-
tary personnel recorded to have sustained a facial frac-
ture underwent STRATEVAC out of theatre.
relationship between mandible fracture treatment and 
provision of tracheostomy
All casualties who had a tracheostomy reported in this 
study had it performed prior to evacuation; however, the 
data cannot identify the exact temporal relation between 
tracheostomy and facial fracture treatment. No trache-
ostomies were performed for respiratory weaning. The 
proportion of US military survivors with mandibular frac-
tures having tracheostomy was 250/694 (36%) compared 
with 8/49 (16%) for UK military survivors; χ2: 6.989; 
p≤0.0082 (table 5). Multiple logistic regression demon-
strated that the odds of requiring a tracheostomy were 
highest in the presence of mandible fractures (OR: 8.0, 
95% CI 6.88 to 9.34, p<0.001) and casualties treated in 
US MTF instead of an UK MTF (OR: 3.03, 95% CI 2.13 
to 4.32, p<0.001, table 6). ISS had no effect on the odds 
of having a tracheostomy. US military casualties who had 
treatment of their mandible fracture (ORIF or MMF) 
were less likely to have had a tracheostomy than those not 
treated (OR: 0.61, 95% CI 0.44 to 0.86; p=0.0066).
treatment of mandible fractures in role 3 uS MtF over time
There was a distinct shift in the US management of 
mandible fractures over time (figure 2). There was a 
sharp increase in operative treatment between 2004 and 
2006, and then a gradual decline. The proportion of 
cases managed with closed reduction fell while there was 
a concomitant increase in the use of ORIF, with the ratio 
changing from 3:2 to 1:2.
dISCuSSIOn
The face signals ‘gender, age, social and familial identity, 
ethnicity, emotion and much more besides’.21 In the immediate 
aftermath of the First World War, injury to the face with 
facial disfigurement was described in the lay press as ‘the 
worst loss of all’.22 In the Times History of WWI published 
in 1916, soldiers with facial injury and disfigurement were 
described as ‘the most tragic of all war's victims’.23 Tech-
niques of reconstruction are radically different today; 
however, highquality management of patients with facial 
injury remains a fundamental duty for military surgical 
teams. To our knowledge, this is the largest analysis of 
patients with facial wounds treated in coalition MTF in 
Iraq and Afghanistan. The study breaks new ground as 
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Table 4 Overall numbers of surgical interventions performed on survivors in different casualty populations
Group
2015 ICD-9 procedure 
codes
OPCS-4 procedure 
codes
US 
military
UK 
military
Other 
coalition 
military
Host nation 
military
Host nation 
civilians
Open or closed reduction of any 
facial fracture
655 0 37 737 787
Open reduction of mandible 
fracture
76.76 V15.2, V17.2, V17.8, 
V17.9
258 0 8 179 404
Closed reduction of mandible 
fracture
76.75 V15.3, V17.2, V17.3 140 0 15 84 113
Open or closed reduction of 
mandible fracture
76.75, 76.76 V15.1, V15.2, V15.3, 
V15.8, V15.9, V17.3
385 0 22 242 499
Open or closed reduction of 
maxilla fracture
76.73, 76.74 V08.1- V08.3, V08.8, 
V08.9, V11.1- V11.4
115 0 4 73 101
Open reduction of zygoma 
fracture
76.71, 76.72 V09.3 83 0 2 77 105
Open reduction of orbital fracture 16.01, 16.02, 16.09 C08.2, C08.5 22 0 1 13 22
Facial soft tissue debridement/
repair
21.81, 24.32, 25.51, 
25.59, 26.41, 27.51–
27.61, 27.69
S56.1 1859 206 188 605 1021
Ligation of facial vessel 21.00–21.06, 21.09, 
38.12, 38.62, 38.82
E12.1, L30.2 191 4 31 75 113
Repair of intra oral damage 27.43–27.61, 27.69, 
27.92–27.99
F40.4, F40.9 560 7 45 174 267
Lateral canthotomy 8.51 C11.6 83 4 13 47 77
Surgical tracheostomy with facial 
injury
31.1, 31.12, 31.29, 
31.74
E42.1, E42.3 323 13 29 361 502
Numbers relate to patients treated, not to individual surgical procedures.
ICD-9, International Classification of Disease version 9; OPCS, Classification of Interventions and Procedures.
Figure 1 Proportions of different injury types found in survivors and treated according to medical treatment facility (MTF). 
Numbers relate to patients treated, not to individual surgical procedures. MMF, mandibulo- maxillary fixation; ORIF, open 
reduction and internal fixation.
it is the first to directly compare treatment delivered by 
US and UK military medical providers. The proportion 
of facial injuries was higher than in most conflicts prior 
to the 21st century, likely reflecting the enhanced effec-
tiveness of helmets and body armour in reducing number 
and severity of head and truncal injury and wounding 
patterns due to the use of improvised explosive devices 
later in the Afghanistan conflict.17 24 The proportion of 
facial wounds was higher in local civilians and local mili-
tary, reflecting almost universal use of combat helmets by 
US and UK military members and the use of ballistic eye 
protection from 2005 onwards.24 The data in this study 
extend to 2011 only as military permissions to access data 
did not extend beyond this. We acknowledge that there 
may be trends after date that might make a difference 
to the incidence of injury, in particular for the UK mili-
tary, such as the introduction of the UK Mark 7 helmet 
at end of 2010, the patrol neck collar in 2013,24 and the 
VIRTUS visor and mandible guard in 2015.25 Although 
the UK had lower volumes of facial injuries through 
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Table 5 Effect of facial fracture treatment on provision of 
tracheostomy in survivors to a role 3 MTF
Patient cohort
US military (n 
(%))
UK military 
(n (%))
Survivors with mandible 
fractures
694 (100) 50 (100)
Survivors with mandible 
fractures having 
tracheostomy
250/694 (36) 8/50 (16)
Survivors with mandible 
fractures managed by ORIF 
or MMF
382/694 (55) 0/50 (0)
Survivors with mandible 
fractures managed by ORIF 
or MMF having tracheostomy
51/382 (13.3) 0/50 (0)
Survivors with mandible 
fractures not fixed having 
tracheostomy
199/312 (63.7) 8/50 (16)
MMF, mandibulo- maxillary fixation (stabilisation); ORIF, open 
reduction and internal fixation (definitive treatment).
Table 6 Results of multivariate logistic regression analysis with tracheostomy as dependent variable and coalition military 
casualty (including US and UK), ISS grouping, mandible fracture and no treatment of mandible fracture as independent 
variables
Tracheostomy OR SE Z P>|z| 95% CI
Treatment in US MTF 3.033696 0.5472023 6.15 0 2.13028 4.320235
Coalition military 0.4257238 0.0292904 −12.41 0 0.3720181 0.4871828
Mandible fracture present 8.021444 0.6257567 26.69 0 6.884143 9.346633
No treatment of mandible fracture 0.7424999 0.0770788 −2.87 0.004 0.6058057 0.9100379
ISS group 3–15 0.1356279 0.0106448 −25.45 0 0.1162899 0.1581816
ISS group 16–24 0.4933107 0.0419693 −8.31 0 0.4175447 0.5828248
ISS group 25–75 1 (omitted)
ISS, Injury Severity Score; MTF, medical treatment facilities.
their deployed MTFs, reflecting the lower proportions of 
troops numbers, all evacuated coalition casualties were 
managed in a single level 1/major trauma centre in the 
UK (RCDM). This has enabled consolidation of institu-
tional knowledge and potentially optimised outcomes.
Contrast is apparent between the management of facial 
fractures in US versus UK MTF. The difference almost 
entirely related to the management of mandible frac-
tures, with 692/1452 (48%) stabilised in role 3 US MTF 
and (although 7/167 (1%) of mandible fractures had a 
bridle wire placed in UK MTF), none had formal MMF 
or ORIF. This reflected the accepted and taught practice 
in UK MTF.19 26–32 The US Department of Defense (DoD) 
purposefully deployed US surgeons who regularly treated 
facial skeletal trauma in their day- to- day role in mainland 
USA. UK military plastic surgeons were deployed to the 
role 2E MTF at Camp Bastion from 2008 but did not repair 
facial fractures on coalition military or local nationals. 
UK military OMF surgeons deployed to the Canadian- led 
role 3 MTF in Kandahar from 2006 and repaired facial 
fractures and performed surgical tracheostomies on 
local nationals but only stabilised coalition military as 
the policy for this cohort was for rapid evacuation. Initial 
management of facial injury was taught to deploying 
UK surgical teams on the Military Operational Surgical 
Training predeployment course, which included stabilisa-
tion of mandibular fractures with arch- bars.26 27 Complete 
results from Kandahar are not included in this paper as, 
during the date range studied, they are held in the Cana-
dian deployed trauma care registry. However, published 
data demonstrated that MMF, ORIF and external fixa-
tion were performed by UK OMF surgeons in Kandahar 
on both local military personnel and local civilians with 
minimal recorded complications.6 7 28 29 At times, UK 
and other individuals injured in the area of operations 
covered by the UK hospital at Camp Bastion who had 
significant cranio- facial injury were flown directly to the 
MTF in Kandahar to enable specialist neurosurgical care.
The sharp increase in in- theatre operative treatment of 
facial fractures by US forces, including the proportion-
ally greater use of ORIF compared with closed reduction 
between 2004 and 2006, coincided with the publication 
by Lopez et al demonstrating the safety of facial frac-
ture repair in Iraq prior to evacuation.30 Although it did 
not become formal US DoD policy, this principle was 
employed by many US deployed surgeons. The effec-
tiveness and safety of this approach has been further 
confirmed in multiple studies.19 31–34 Such early manage-
ment of facial fractures must be contrasted to those open 
fractures of the limbs, which most authorities agree 
should not be treated by open fixation early. The main 
stated contraindication to early definitive ORIF of facial 
fractures was that it would potentially delay evacuation.30 
The notion that a high energy transfer wound is a contra-
indication to early ORIF of mandible fractures has now 
generally been discredited.35–38 Strong evidence exists 
that early management of such injuries is safe and leads 
to improved outcomes.39 In fact, delaying treatment of 
facial fractures has been demonstrated to increase patient 
pain, increase the likelihood of requiring a tracheostomy 
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Figure 2 Proportions of all mandible fractures treated surgically over time in US medical treatment facilities. The vertical line in 
2005 demonstrates when the paper by Lopez et al30 was published.
and to result in poorer outcomes for complex fractures, 
particularly those with avulsive soft tissue defects.5 34 Kittle 
et al5 demonstrated that military patients with facial frac-
tures treated within 2 days of injury had lower compli-
cation rates and fewer returns to theatre than those left 
longer than 5 days for treatment back in the USA. This is 
particularly relevant, as our results are derived from two 
conflicts in which rapid evacuation of US and UK mili-
tary personnel was possible, generally within 48 hours of 
injury.15 19 26 34 For example, one analysis of UK military 
injuries during Iraq demonstrated a mean time period 
between injury and treatment at role 4 in Birmingham, 
UK of 2 days.40 The ability to achieve rapid aeromedical 
evacuation is predicated on coalition air dominance in 
the theatre of operations with rapid tactical medical evac-
uation from point of wounding to the role 2 or role 3 
MTF (TACEVAC) and the ready availability of aircraft for 
strategic (out of theatre) medical evacuation (STRAT-
EVAC). The topography and weather conditions of the 
Iraqi theatre of operations were generally acceptable for 
sustained flight operations, with air dominance obtained 
early in the conflict and maintained throughout the 
entirety of combat operations. In Afghanistan, TACEVAC 
was sometimes delayed due to weather conditions and alti-
tude restrictions in mountainous regions of the country. 
Future conflicts are unlikely to see such rapid TACEVAC 
and STRATEVAC,26 and therefore treatment of facial 
fractures, in forward MTF, may be required to mitigate 
preventable morbidity.
In US MTF, treating mandible fractures prior to STRAT-
EVAC reduced the rate of tracheostomy fivefold (from 
64% to 13%). The US rate of tracheostomy placement 
for mandibular fractures was 36% compared with 16% 
for UK- managed cases. We accept that there are require-
ments for tracheostomy in a small number of patients 
with mandibular fractures, although clinicians at UK 
MTF were able to intubate the vast majority of coalition 
casualties prior to evacuation. However, we believe that 
during this period, the data match the experience of the 
authors, in that US military clinicians had a relatively low 
threshold to undertake tracheostomy. Where delay may 
occur in future conflicts and hence inpatient care may 
be required in theatre for longer, a relatively quick oper-
ation to stabilise the facial skeleton may render a patient 
self- ventilating, rather than requiring high- dependency 
care, without the need for a tracheostomy ever to be 
placed.
A UK military multidisciplinary consensus statement 
from 2018 proposed that the surgical skills required to 
manage facial injuries in a deployed MTF (roles 1–3) in 
the first 24 hours after injury are: facial vascular haemor-
rhage control, facial fracture stabilisation, lateral ocular 
canthotomy and surgical tracheostomy. This study reveals 
variation in the use of tracheostomy after facial injury but 
supports the contention that the ability to stabilise facial 
fractures soon after wounding offers the advantages of 
improved clinical outcomes and can significantly reduce 
the requirement for tracheostomy. The authors recognise 
that a major limitation of this study is the lack of standard-
isation between the two trauma registries, limiting further 
outcome analyses between nations. The components of 
midface fractures (zygoma, maxilla and orbit) are coded 
individually, but may overlap, increasing the incidence 
of individual fractures. In addition, it is not possible to 
collate long- term outcome data in the US system due to 
the lack of uniformity of reporting methods, no national 
health database and the loss of patients to the private 
sector once they leave, or are retired from, military 
service.
This is the first study to have access to both US and UK 
trauma databases making true comparisons between them 
possible. Our findings suggest that the capability to surgi-
cally treat mandible fractures by ORIF and MMF should 
be considered as an integral component of deployed 
coalition surgical care in the future.
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